Aruda, Aspire blah blah blah all that matters is Kevetrin, Brilacidin and Prurisol and I have not heard or read one negative thing yet. The science wins out and Cellceutix gets it's day in the limelght...and then we're off to the races. It will happen if the former is true.
ECCMID, ASCO, Uplist, trials resumption all catalysts to turn us back up and all catalysts to find a wider audience. We need exposure!!!
Have a good weekend everybody.